| Document Date: 2015-06-10 08:00:36
Open Document File Size: 39,33 KBShare Result on Facebook
City FREISING / / Company Stelis Biopharma / Sanofi Group / Zydus Cadila / Pieris Pharmaceuticals Inc. / Daiichi Sankyo / Pieris Pharmaceuticals / Allergan / / Continent Europe / / Country Germany / / Event FDA Phase / / IndustryTerm biotherapeutic technologies / biotechnology / / MedicalCondition functional iron deficiency / end-stage renal disease / anemia / / Person Stephen Yoder / / Position President and CEO / / Product Anticalin / Company / / ProgrammingLanguage EC / / Technology biotechnology / / URL www.eurocalin-fp7.eu / www.pieris.com / / |
June 10, 2015 Pieris Pharmaceuticals Completes Dosing of Healthy Volunteers in Phase I Clinical Trial for Anticalin Program in Anemia PRS-080 Is Second Anticalin Successfully Administered to Humans